🇺🇸 FDA
Patent

US 10517890

Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles

granted A61KA61K31/713A61K47/50

Quick answer

US patent 10517890 (Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The United States of America, as represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
18
CPC classes
A61K, A61K31/713, A61K47/50